Literature DB >> 7976769

Motor vehicle collision injuries and sensory impairments of older drivers.

L W McCloskey1, T D Koepsell, M E Wolf, D M Buchner.   

Abstract

To determine whether ocular disease, impaired vision, or diminished hearing might increase the risk of motor vehicle collision injuries in older drivers, we conducted a population-based case-control study at a large Health Maintenance Organization (HMO). All study subjects were HMO members who were licensed drivers age 65 or over. Cases were drivers treated for injuries sustained in a police-reported collision that occurred in 1987 or 1988. Controls were drivers who experienced no such injury during the study years and were matched to cases by age, sex, and county of residence. We found no clear evidence that ocular diseases or impaired visual acuity, as customarily recorded in the medical record, increased the risk of an injury collision. Although there was no significant association between impaired hearing and injury collision, we found that subjects who used hearing aids while driving had about twice the risk of others (adjusted RR 2.1; 95% CI 1.2-3.8). We conclude that mild reductions in static visual acuity have little effect on the risk of injury collisions for older drivers. Moreover, the types of vision tests needed to identify elderly drivers at increased risk are not those that are generally administered during routine optometry examinations or at the time of licence renewal. Further research is needed to verify a possible increase in risk among elderly drivers using hearing aids.

Entities:  

Mesh:

Year:  1994        PMID: 7976769     DOI: 10.1093/ageing/23.4.267

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  20 in total

Review 1.  Vision and driving.

Authors:  Cynthia Owsley; Gerald McGwin
Journal:  Vision Res       Date:  2010-05-23       Impact factor: 1.886

2.  Examining the association between age-related macular degeneration and motor vehicle collision involvement: a retrospective cohort study.

Authors:  Gerald McGwin; Bradford Mitchell; Karen Searcey; Michael A Albert; Richard Feist; John O Mason; Martin Thomley; Cynthia Owsley
Journal:  Br J Ophthalmol       Date:  2013-07-05       Impact factor: 4.638

3.  What rates of glaucoma progression are clinically significant?

Authors:  Luke J Saunders; Felipe A Medeiros; Robert N Weinreb; Linda M Zangwill
Journal:  Expert Rev Ophthalmol       Date:  2016-05-13

4.  Sensory impairment and driving: the Blue Mountains Eye Study.

Authors:  R Q Ivers; P Mitchell; R G Cumming
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

Review 5.  A roadmap for interpreting the literature on vision and driving.

Authors:  Cynthia Owsley; Joanne M Wood; Gerald McGwin
Journal:  Surv Ophthalmol       Date:  2015-02-07       Impact factor: 6.048

6.  Association of Hearing Impairment and Subsequent Driving Mobility in Older Adults.

Authors:  Jerri D Edwards; Jennifer J Lister; Frank R Lin; Ross Andel; Lisa Brown; Joanne M Wood
Journal:  Gerontologist       Date:  2017-08-01

7.  Stage of visual field loss and age at diagnosis in 1988 patients with different glaucomas: implications for glaucoma screening and driving ability.

Authors:  Gwendolyn Gramer; Eugen Gramer
Journal:  Int Ophthalmol       Date:  2017-02-27       Impact factor: 2.031

8.  Driving simulation as a performance-based test of visual impairment in glaucoma.

Authors:  Felipe A Medeiros; Robert N Weinreb; Erwin R Boer; Peter N Rosen
Journal:  J Glaucoma       Date:  2012 Apr-May       Impact factor: 2.503

9.  Vision impairment and older drivers: who's driving?

Authors:  J E Keeffe; C F Jin; L M Weih; C A McCarty; H R Taylor
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

10.  Associations between visual, hearing, and dual sensory impairments and history of motor vehicle collision involvement of older drivers.

Authors:  Kimberly A Green; Gerald McGwin; Cynthia Owsley
Journal:  J Am Geriatr Soc       Date:  2013-01-25       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.